| Financial Year |
March 31 2023 |
| Monetary Funds |
760,366,987.91 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
1,500,000.00 |
| Accounts Receivable |
259,012,022.54 |
| Advances to Suppliers |
35,904,036.58 |
| Other Receivables |
5,566,948.36 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
313,054,827.87 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
25,026,358.82 |
| Total Current Assets |
1,400,431,182.08 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
812,665,701.47 |
| Under-construction Projects |
23,447,161.83 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
256,158,804.22 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
83,218,536.92 |
| Deferred Income Tax Assets |
22,180,046.46 |
| Other Non-Current Assets |
2,115,157.93 |
| Sub-Total of Non-Current Assets |
1,231,655,407.39 |
| Total Assets |
2,632,086,589.47 |
| Short-Term Loans |
92,000,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
9,678,000.00 |
| Accounts Payable |
137,758,231.89 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
23,528,952.09 |
| Taxes Payable |
15,348,449.47 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
3,613,720.73 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
389,846.42 |
| Other Current Liabilities |
27,853,140.10 |
| Sub-Total of Current Liabilities |
331,709,471.64 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
14,768,909.43 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
51,687,812.47 |
| Total Liabilities |
383,397,284.11 |
| Paid-In Capital(Or Share Stock) |
358,131,567.00 |
| Capital Surplus |
1,011,996,655.27 |
| Surplus Reserve |
112,526,575.38 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
766,034,507.71 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,248,689,305.36 |
| Owner's Equity（Stockholder's Equity） |
2,248,689,305.36 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,632,086,589.47 |
